Tolerance to rat monoclonal antibodies. Implications for serotherapy.
about
Cyclosporin A prevents the anti-murine antibody response to a monoclonal anti-tumour antibody in rabbitsTransplantation tolerance and its outcome during infections and inflammationCo-receptor and co-stimulation blockade for mixed chimerism and tolerance without myelosuppressive conditioning.Interleukin 6 promotes murine lupus in NZB/NZW F1 mice.From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies.Reprogramming the immune system.Reprogramming the immune system for peripheral tolerance with CD4 and CD8 monoclonal antibodies.CD8 blockade promotes the expansion of antigen-specific CD4+ FOXP3+ regulatory T cells in vivoCross-reactive and pre-existing antibodies to therapeutic antibodies--Effects on treatment and immunogenicity.T cell tolerance induced by therapeutic antibodiesThe immunogenicity of chimeric antibodiesImmunosuppression by immunoglobulin deaggregation is not effective in reducing the anti-xenogeneic immunoglobulin response: experimental and clinical studies.CD3-specific antibodies as promising tools to aim at immune tolerance in the clinic.Immune privilege induced by regulatory T cells in transplantation tolerance.Possible therapeutic applications of single-chain antibodies in systemic autoimmune diseases.Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies.Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation.Cancer therapy with trifunctional antibodies: linking innate and adaptive immunity.Boosting regulatory T cell function by CD4 stimulation enters the clinic.Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory disease.Genetically engineered antibody molecules: new tools for cancer therapy.Vectors for the expression of PCR-amplified immunoglobulin variable domains with human constant regions.In Vivo Depletion of T Lymphocytes.Intercellular adhesion molecule (ICAM-1) inhibition can induce tolerance in vivo.Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8.Antibodies as antigens. The use of mouse monoclonal antibodies to focus human T cells against selected targets.Reshaping a human monoclonal antibody to inhibit human respiratory syncytial virus infection in vivo.Depletion of CD4+ and CD8+ cells eliminates immunologic memory of thyroiditogenicity in murine experimental autoimmune thyroiditis.
P2860
Q24645745-65366D27-BBD0-44A1-9EF4-3C0273973D95Q26829817-11BC3E8A-52B3-45DE-AAF5-CEBF1B161D7EQ33241067-F0FCB5BF-BBEE-402B-B047-A3461DEEDA38Q34228814-9E158E4B-8C78-48FE-88C9-2BB280F2A1CEQ34321820-53EA9A85-AFBA-40D4-933E-29D90BEE2D34Q34792489-06B3889A-57C9-43BC-9775-A66B0EB3C9D0Q35595898-B86F5BCF-83F5-4BB9-9D9F-613F8DA5BC08Q35633922-B0E12B1D-7284-4187-AD16-E902077D1A4AQ36214720-43EB4F5B-FED0-4915-87F5-5529A953F4BEQ36251293-69670208-5311-4784-A40B-0FFC3E1AD732Q36357164-B9EDFA09-F2C4-45A4-8440-3E07C1B1FB2CQ36467488-4A5BFA26-4D35-42D0-BFAB-2BC36C883398Q36526356-EB87A8C0-84DA-4175-ABD9-3EC042739AFCQ36593774-57A24B03-9820-42B5-9474-8CEF98E4854FQ36810295-CA11A405-FF25-41BD-B614-0D76654E8132Q36830998-5B14CAB0-0447-4B49-A193-220FA1CB079EQ37189831-7C1A17CF-DBDD-4492-9064-61A3C3093BE3Q37773272-DEEB2C4C-DFD8-4C9C-A76F-74F0278FE2FFQ37965555-CA182DA3-D261-448D-AA80-A5DA6D12E2BAQ38020477-83A3E8AD-9F32-4B1A-B7C7-324ABE0D918FQ39452477-38BE58F0-3922-4ED5-A4E8-AF2FB870958FQ39644773-DA6EB7B0-2B95-4184-8C5B-A8E104401BB2Q40407910-24719CD3-B8B1-4CA3-B7ED-1F01447869F3Q40731200-70FA2F4F-22ED-43BF-9921-7F99A06CF516Q41135190-2ACE5E76-A003-43DC-A43B-1B80577D7805Q41326954-A04314E3-9922-4C02-9931-46CB6101B06EQ41885910-D9E591FB-F8DC-4A34-A348-5C81DDBA3820Q45874080-D73BC806-2488-4381-AEEC-15B4D9A1BB71Q52059885-F910CA29-0D85-4D25-A654-97B2041EFE7E
P2860
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
@en
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
@nl
type
label
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
@en
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
@nl
prefLabel
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
@en
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
@nl
P2093
P2860
P356
P1476
Tolerance to rat monoclonal antibodies. Implications for serotherapy.
@en
P2093
P2860
P304
P356
10.1084/JEM.163.6.1539
P407
P577
1986-06-01T00:00:00Z